Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice

American Journal of Transplantation

Volumn 2, Issue 6, 2002, Pages 501-509

  Valujskikh, Anna ^a,c   Pantenburg, Birte ^b   Heeger, Peter S ^a,c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Blockade; Costimulatory; Memory; T cell; Tolerance; Transplantation

Indexed keywords

ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD40 LIGAND; CD8 ANTIGEN;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; SKIN GRAFT; T LYMPHOCYTE; TRANSFUSION;

ANIMALS; CD40 LIGAND; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INTERFERON TYPE II; MALE; MICE; SKIN TRANSPLANTATION; T-LYMPHOCYTES;

EID: 0036664218     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20603.x     Document Type: Article

References (42)

1. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998; 10 (5): 518-524.
2. Arima T, Lehmann M, Flye MW. Induction of donor specific transplantation tolerance to cardiac allografts following treatment with nondepleting (RIB 5/2) or depleting (OX-38) anti-CD4 mAb plus intrathymic or intravenous donor alloantigen. Transplantation 1997; 63 (2): 284-292.
3. Dallman MJ, Wood KJ, Hamano K et al. Cytokines and peripheral tolerance to alloantigen. Immunol Rev 1993; 133: 5-18.
4. Onodera K, Lehmann M, Akalin E, Volk HD, Sayegh MH, Kupiec-Weglinski JW. Induction of 'infectious' tolerance to MHC-incompatible cardiac allografts in CD4 monoclonal antibody-treated sensitized rat recipients. J Immunol 1996; 157 (5): 1944-1950.
5. Ossevoort MA, Ringers J, Kuhn EM et al. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway. Transplantation 1999; 68 (7): 1010-1018.
6. Cho CS, Burkly LC, Fechner JH Jr. et al. Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. Transplantation 2001; 72 (4): 587-597.
7. Salama AD, Remuzzi G, Harmon WE, Sayegh MH. Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001; 108 (7): 943-948.
8. Deacock SJ, Lechler RI. Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients. Transplantation 1992; 54 (2): 338-343.
9. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163 (4): 2267-2275.
10. Baid S, Saidman SL, Tolkoff-Rubin N et al. Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol 2001; 13 (5): 577-581.
11. van Besouw NM, van der Mast BJ, de Kuiper P et al. Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation 2000: 70 (1): 136-143.
12. Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381 (6581): 434-438.
13. Markees TG, Phillips NE, Noelle RJ et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 1997; 64 (2): 329-335.
14. Markees TG, Phillips NE, Gordon EJ et al. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4 (+) T cells, interferon-gamma, and CTLA4. J Clin Invest 1998; 101 (11): 2446-2455.
15. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A 1996; 93 (24): 13967-13972.
16. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5 (6): 686-693.
17. Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164 (1): 512-521.
18. Taylor PA, Noelle RJ, Blazar BR. CD4 (+) CD25 (+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001; 193 (11): 1311-1318.
19. Pihlgren M, Dubois PM, Tomkowiak M, Sjogren T, Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J Exp Med 1996; 184 (6): 2141-2151.
20. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996; 273 (5271): 104-106.
21. London CA, Lodge MP, Abbas AK. Functional responses and costimulator dependence of memory CD4+ T cells. J Immunol 2000; 164 (1): 265-272.
22. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000; 290 (5489): 92-97.
23. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162 (1): 352-358.
24. Heeger PS, Valujskikh A, Lehmann PV. Comprehensive assessment of determinant specificity, frequency, and cytokine signature of the primed CD8 cell repertoire induced by a minor transplantation antigen. J Immunol 2000; 165 (3): 1278-1284.
25. Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65 (7): 906-914.
26. Padovan E, Casorati G, Dellabona P, Meyer S, Brockhaus M, Lanzavecchia A. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 1993; 262 (5132): 422-424.
27. Liu Z, Sun YK, Xi YP et al. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 1993; 177 (6): 1643-1650.
28. Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R. CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol 1999; 163 (6): 3194-3201.
29. Trambley J, Bingaman AW, Lin A et al. Asialo GM1 (+) CD8 (+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104 (12): 1715-1722.
30. Williams MA, Trambley J, Ha J et al. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000; 165 (12): 6849-6857.
31. Guo Z, Meng L, Kim O et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71 (9): 1351-1354.
32. Williams MA, Tan JT, Adams AB et al. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol 2001; 167 (9): 4987-4995.
33. Welsh RM, Markees TG, Woda BA et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol 2000; 74 (5): 2210-2218.
34. Croft M, Bradley LM, Swain SL. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 1994; 152 (6): 2675-2685.
35. Dubey C, Croft M, Swain SL. Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals. J Immunol 1996; 157 (8): 3280-3289.
36. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998; 16: 201-223.
37. Garcia S, DiSanto J, Stockinger B. Following the development of a CD4 T cell response in vivo: from activation to memory formation. Immunity 1999; 11 (2): 163-171.
38. Grayson JM, Murali-Krishna K, Altman JD, Ahmed R. Gene expression in antigen-specific CD8 (+) T cells during viral infection. J Immunol 2001; 166 (2): 795-799.
39. Grayson JM, Zajac AJ, Altman JD, Ahmed R. Cutting edge, increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J Immunol 2000; 164 (8): 3950-3954.
40. Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995; 181 (2): 713-721.
41. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995; 2 (6): 665-675.
42. Kupiec-Weglinski JW. Graft rejection in sensitized recipients. Ann Transplant 1996; 1 (1): 34-40.